Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Profit & Loss account - Aurobindo Pharma

Aurobindo Pharma

BSE: 524804|NSE: AUROPHARMA|ISIN: INE406A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 13, 16:00
449.20
0.6 (0.13%)
VOLUME 89,216
LIVE
NSE
Dec 13, 15:59
449.35
0.6 (0.13%)
VOLUME 2,964,208
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Profit & Loss account of Aurobindo Pharma

------------------- in Rs. Cr. -------------------
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
12 mths 12 mths 12 mths 12 mths 12 mths
INCOME
Revenue From Operations [Gross] 11,938.70 10,041.96 9,539.36 9,078.96 8,167.75
Less: Excise/Sevice Tax/Other Levies 0.00 33.25 174.16 156.58 149.74
Revenue From Operations [Net] 11,938.70 10,008.71 9,365.20 8,922.38 8,018.01
Other Operating Revenues 319.19 261.19 241.85 243.80 77.09
Total Operating Revenues 12,257.89 10,269.90 9,607.05 9,166.18 8,095.10
Other Income 199.22 80.65 135.95 188.36 67.22
Total Revenue 12,457.11 10,350.55 9,743.00 9,354.54 8,162.32
EXPENSES
Cost Of Materials Consumed 6,455.30 4,893.27 4,604.19 4,425.80 3,920.33
Purchase Of Stock-In Trade 14.25 3.72 11.21 6.31 15.76
Changes In Inventories Of FG,WIP And Stock-In Trade -289.80 -337.20 31.32 -141.59 -159.09
Employee Benefit Expenses 1,362.77 1,131.64 927.30 807.05 668.75
Finance Costs 230.86 52.89 45.16 229.31 132.14
Depreciation And Amortisation Expenses 413.03 354.83 286.17 263.00 245.15
Other Expenses 2,306.08 1,908.46 1,659.08 1,616.82 1,398.93
Total Expenses 10,492.49 8,007.61 7,564.43 7,206.70 6,221.97
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
12 mths 12 mths 12 mths 12 mths 12 mths
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 1,964.62 2,342.94 2,178.57 2,147.84 1,940.35
Profit/Loss Before Tax 1,964.62 2,342.94 2,178.57 2,147.84 1,940.35
Tax Expenses-Continued Operations
Current Tax 426.61 505.34 462.06 518.23 420.63
Less: MAT Credit Entitlement 48.05 43.32 64.28 0.00 9.95
Deferred Tax 56.33 68.15 74.03 2.91 13.32
Total Tax Expenses 434.89 530.17 471.81 521.14 424.00
Profit/Loss After Tax And Before ExtraOrdinary Items 1,529.73 1,812.77 1,706.76 1,626.70 1,516.35
Profit/Loss From Continuing Operations 1,529.73 1,812.77 1,706.76 1,626.70 1,516.35
Profit/Loss For The Period 1,529.73 1,812.77 1,706.76 1,626.70 1,516.35
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
12 mths 12 mths 12 mths 12 mths 12 mths
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.) 26.11 30.94 29.16 27.85 52.01
Diluted EPS (Rs.) 26.11 30.94 29.16 27.85 51.97
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS
Imported Raw Materials 0.00 0.00 0.00 0.00 2,153.63
Indigenous Raw Materials 0.00 0.00 0.00 0.00 1,766.70
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares 0.00 0.00 0.00 15.15 9.77
Indigenous Stores And Spares 0.00 0.00 0.00 122.76 106.20
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend 146.48 219.71 114.11 134.37 131.28
Tax On Dividend 13.86 44.73 23.23 27.36 25.04
Equity Dividend Rate (%) 250.00 250.00 250.00 250.00 300.00
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for aurobindopharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.